Poll of the Week: Do You Use a Tablet?
Tablet use among physicians has nearly doubled since 2011, with 62 percent of doctors using them on the job. Do you?
Tablet use among physicians has nearly doubled since 2011, with 62 percent of doctors using them on the job, according to a recent study from healthcare market research firm Manhattan Research.
Half of the tablet-owning doctors have used the device at the point of the care, and the iPad is the dominant platform, the study found.
Overall, physicians’ device and digital media adoption has grown faster than anticipated, according to the study that surveyed 3,015 U.S. doctors across more than 25 specialties.
There are dozens of medical imaging iPad apps, including Mobile MIM, the first diagnostic radiology app approved by the FDA for viewing images and making medical diagnoses based on CT, MRI and nuclear medicine technology.
Have you joined the tablet craze?
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
